These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 1963497)
21. Neurotransmitters, anxiety and benzodiazepines: a behavioral review. Shephard RA Neurosci Biobehav Rev; 1986; 10(4):449-61. PubMed ID: 2880326 [TBL] [Abstract][Full Text] [Related]
22. Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders. Morilak DA; Frazer A Int J Neuropsychopharmacol; 2004 Jun; 7(2):193-218. PubMed ID: 15003145 [TBL] [Abstract][Full Text] [Related]
23. The GABA-benzodiazepine receptor complex: structure, function, and role in anxiety. Roy-Byrne PP J Clin Psychiatry; 2005; 66 Suppl 2():14-20. PubMed ID: 15762815 [TBL] [Abstract][Full Text] [Related]
24. Disinhibition of the rat prelimbic cortex promotes serotonergic activation of the dorsal raphe nucleus and panicolytic-like behavioral effects. Yamashita PS; Spiacci A; Hassel JE; Lowry CA; Zangrossi H J Psychopharmacol; 2017 Jun; 31(6):704-714. PubMed ID: 28071216 [TBL] [Abstract][Full Text] [Related]
25. Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment. Charney DS; Heninger GR Arch Gen Psychiatry; 1985 May; 42(5):458-67. PubMed ID: 2859008 [TBL] [Abstract][Full Text] [Related]
26. Serotonin agents in anxiety. Taylor DP Ann N Y Acad Sci; 1990; 600():545-56; discussion 556-7. PubMed ID: 2252334 [TBL] [Abstract][Full Text] [Related]
27. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam. Klein E J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116 [TBL] [Abstract][Full Text] [Related]
28. The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias. Sullivan GM; Coplan JD; Kent JM; Gorman JM Biol Psychiatry; 1999 Nov; 46(9):1205-18. PubMed ID: 10560026 [TBL] [Abstract][Full Text] [Related]
29. Serotonin related functions in panic-anxiety: a critical overview. Coplan JD; Gorman JM; Klein DF Neuropsychopharmacology; 1992 May; 6(3):189-200. PubMed ID: 1534662 [TBL] [Abstract][Full Text] [Related]
30. New molecular targets for antianxiety interventions. Gorman JM J Clin Psychiatry; 2003; 64 Suppl 3():28-35. PubMed ID: 12662131 [TBL] [Abstract][Full Text] [Related]
31. Quetiapine anxiolytic-like effect in the Vogel conflict test is serotonin dependent. Pisu C; Pira L; Pani L Behav Pharmacol; 2010 Oct; 21(7):649-53. PubMed ID: 20802307 [TBL] [Abstract][Full Text] [Related]
32. The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies. Kalk NJ; Nutt DJ; Lingford-Hughes AR J Psychopharmacol; 2011 Jan; 25(1):3-16. PubMed ID: 20530586 [TBL] [Abstract][Full Text] [Related]
33. Future directions in anxiolytic pharmacotherapy. Kunovac JL; Stahl SM Psychiatr Clin North Am; 1995 Dec; 18(4):895-909. PubMed ID: 8748388 [TBL] [Abstract][Full Text] [Related]
34. Serotonin: a common neurobiologic substrate in anxiety and depression. Eison MS J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):26S-30S. PubMed ID: 2198299 [TBL] [Abstract][Full Text] [Related]
35. Serotonin receptors in depression and anxiety: Insights from animal studies. Żmudzka E; Sałaciak K; Sapa J; Pytka K Life Sci; 2018 Oct; 210():106-124. PubMed ID: 30144453 [TBL] [Abstract][Full Text] [Related]
36. Anxiety and the benzodiazepine receptor. Norman TR; Burrows GD Prog Brain Res; 1986; 65():73-90. PubMed ID: 3024225 [No Abstract] [Full Text] [Related]
38. Angiotensin as stress mediator: role of its receptor and interrelationships among other stress mediators and receptors. Bali A; Jaggi AS Pharmacol Res; 2013 Oct; 76():49-57. PubMed ID: 23892268 [TBL] [Abstract][Full Text] [Related]
39. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety. Murphy DL; Pigott TA J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026 [TBL] [Abstract][Full Text] [Related]
40. [Mechanism of action, indications and abuse of benzodiazepine anxiolytic drugs]. Goffinet S Ann Med Psychol (Paris); 1993 Jan; 151(1):47-63. PubMed ID: 7905724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]